 3. Has clinical evidence of anatomic or pathological hypothalamicpituitarytesticular disease, such as but not limited to Klinefelters syndrome, Kallmanns syndrome, systemic infiltrative diseases hemochromatosis, sarcoidosis, Wilsons disease, or prior pituitary surgery. 